載入...
Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity
PURPOSE: The purpose of this study was to report on the axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for threshold retinopathy of prematurity. METHODS: The authors conducted a comparative, consecutive, original study. RESULTS: Twenty-five ey...
Na minha lista:
| 發表在: | Clin Ophthalmol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4959583/ https://ncbi.nlm.nih.gov/pubmed/27499611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S110717 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|